The association of obesity with cardiovascular events in patients with peripheral artery disease

Atherosclerosis

Volumn 228, Issue 2, 2013, Pages 316-323

  Cronin, Oliver ^a   Morris, Dylan R ^a   Walker, Philip J ^a,b,c   Golledge, Jonathan ^a,b,d  

^a JAMES COOK UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d TOWNSVILLE HOSPITAL   (Australia)

Author keywords

Atherothrombosis; Body mass index; Cardiovascular events; Intermittent claudication; Obesity; Peripheral artery disease; Waist circumference; Waist to hip ratio

Indexed keywords

BODY MASS; DISEASE ASSOCIATION; HEART INFARCTION; HUMAN; OBESITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVIEW; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADIPOSITY; AGED; AGED, 80 AND OVER; BODY MASS INDEX; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; STROKE; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84878109037     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.03.002     Document Type: Review

References (57)

1. Hirsch A.T., Criqui M.H., Treat-Jacobson D., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. The Journal of the American Medical Association 2001 Sep 19, 286(11):1317-1324.
2. Belch J.J., Topol E.J., Agnelli G., et al. Critical issues in peripheral arterial disease detection and management: a call to action. Archives of Internal Medicine 2003 Apr 28, 163(8):884-892.
3. Margolis J., Barron J.J., Grochulski W.D. Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data. Journal of Managed Care Pharmacy 2005 Nov-Dec, 11(9):727-734.
4. Krempf M., Parhofer K.G., Steg P.G., et al. Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). The American Journal of Cardiology 2010 Mar 1, 105(5):667-671.
5. Guerrero M., Harjai K., Stone G.W., et al. Usefulness of the presence of peripheral vascular disease in predicting mortality in acute myocardial infarction patients treated with primary angioplasty (from the Primary Angioplasty in Myocardial Infarction Database). The American Journal of Cardiology 2005 Sep 1, 96(5):649-654.
6. Behar S., Zion M., Reicher-Reiss H., Kaplinsky E., Goldbourt U. Short- and long-term prognosis of patients with a first acute myocardial infarction with concomitant peripheral vascular disease. SPRINT Study Group. The American Journal of Medicine 1994 Jan, 96(1):15-19.
7. Alberts M.J., Bhatt D.L., Mas J.L., et al. Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. European Journal of Heart 2009 Oct, 30(19):2318-2326.
8. Golledge J., Leicht A., Crowther R.G., Clancy P., Spinks W.L., Quigley F. Association of obesity and metabolic syndrome with the severity and outcome of intermittent claudication. Journal of Vascular Surgery 2007 Jan, 45(1):40-46.
9. Calle E.E., Thun M.J., Petrelli J.M., Rodriguez C., Heath C.W. Body-mass index and mortality in a prospective cohort of U.S. adults. The New England Journal of Medicine 1999 Oct 7, 341(15):1097-1105.
10. Adams K.F., Schatzkin A., Harris T.B., et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. The New England Journal of Medicine 2006 Aug 24, 355(8):763-778.
11. Hu G., Tuomilehto J., Silventoinen K., Sarti C., Mannisto S., Jousilahti P. Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Archives of Internal Medicine 2007 Jul 9, 167(13):1420-1427.
12. Wang Z.J., Zhao Y.X., Liu Y.Y., et al. Sex difference in the effect of obesity on prognosis for patients undergoing percutaneous coronary intervention. Coronary Artery Disease 2012 Sep, 23(6):404-411.
13. Wang Z.J., Zhou Y.J., Liu Y.Y., et al. Obesity and cardiovascular thrombotic events in patients undergoing percutaneous coronary intervention with drug-eluting stents. Heart (British Cardiac Society) 2009 Oct, 95(19):1587-1592.
14. Sarno G., Garg S., Onuma Y., et al. The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with biolimus- and sirolimus-eluting stents (from the LEADERS Trial). The American Journal of Cardiology 2010 Feb 15, 105(4):475-479.
15. Dagenais G.R., Yi Q., Mann J.F., Bosch J., Pogue J., Yusuf S. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. American Heart Journal 2005 Jan, 149(1):54-60.
16. Yusuf S., Hawken S., Ounpuu S., et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005 Nov 5, 366(9497):1640-1649.
17. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004 Sep 11-17, 364(9438):937-952.
18. Li C., Engstrom G., Hedblad B., Calling S., Berglund G., Janzon L. Sex differences in the relationships between BMI, WHR and incidence of cardiovascular disease: a population-based cohort study. International Journal of Obesity 2006 Dec, 30(12):1775-1781.
19. Freiberg M.S., Pencina M.J., D'Agostino R.B., Lanier K., Wilson P.W., Vasan R.S. BMI vs. waist circumference for identifying vascular risk. Obesity (Silver Spring, Md) 2008 Feb, 16(2):463-469.
20. Reilly M.P., Lehrke M., Wolfe M.L., Rohatgi A., Lazar M.A., Rader D.J. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005 Feb 22, 111(7):932-939.
21. Jung H.S., Park K.H., Cho Y.M., et al. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovascular Research 2006 Jan, 69(1):76-85.
22. Myers J., Powell A., Smith K., Fonda H., Dalman R.L. Cardiopulmonary exercise testing in small abdominal aortic aneurysm: profile, safety, and mortality estimates. European Journal of Cardiovascular Prevention and Rehabilitation 2011 Jun, 18:459-466.
23. Myers J.N., White J.J., Narasimhan B., Dalman R.L. Effects of exercise training in patients with abdominal aortic aneurysm: preliminary results from a randomized trial. Journal of Cardiopulmonary Rehabilitation & Prevention 2010 Nov-Dec, 30(6):374-383.
24. Brenner I., Parry M., Brown C.A. Exercise interventions for patients with peripheral arterial disease: a review of the literature. The Physician and Sports Medicine 2012 May, 40(2):41-55.
25. Shammas N.W. Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. Vascular Health and Risk Management 2007, 3(2):229-234.
26. Weitz J.I., Byrne J., Clagett G.P., et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996 Dec 1, 94(11):3026-3049.
27. Kannel W.B., Wolf P.A. Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: insights from the Framingham Study. Current Atherosclerosis Reports 2006 Jul, 8(4):317-323.
28. Tjandra J., Clunie G., Kaye A., Smith J. Textbook of surgery 2006, Blackwell Publishing Ltd, Carlton, Australia. 3rd ed.
29. Diehm C., Allenberg J.R., Pittrow D., et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009 Nov 24, 120(21):2053-2061.
30. Meves S.H., Diehm C., Berger K., et al. Peripheral arterial disease as an independent predictor for excess stroke morbidity and mortality in primary-care patients: 5-year results of the getABI study. Cerebrovascular Diseases (Basel, Switzerland) 2010, 29(6):546-554.
31. Bhatt D.L., Eagle K.A., Ohman E.M., et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. The Journal of the American Medical Association 2010 Sep 22, 304(12):1350-1357.
32. Barba R., Bisbe J., Pedrajas J.N., et al. Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA registry. European Journal of Cardiovascular Prevention and Rehabilitation 2009 Aug, 16(4):457-463.
33. Giugliano G., Brevetti G., Laurenzano E., Brevetti L., Luciano R., Chiariello M. The prognostic impact of general and abdominal obesity in peripheral arterial disease. International Journal of Obesity 2010 Feb, 34(2):280-286.
34. Lakshmanan R., Hyde Z., Jamrozik K., Hankey G.J., Norman P.E. Population-based observational study of claudication in older men: the Health in Men Study. Medical Journal of Australia 2010 Jun 7, 192(11):641-645.
35. Reid C.M., Ademi Z., Nelson M.R., et al. Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis. Medical Journal of Australia 2012 Feb 20, 196(3):193-197.
36. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization technical report series 2000, vol. 894(i-xii):1-253.
37. World Health Organisation Obesity and overweight 2011, [cited 2011 15/09/11]; Available from:. http://www.who.int/medacentre/factsheets/fs311/en/.
38. European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and other societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). European Journal of Preventive Cardiology 2012 Aug, 19(4):585-667.
39. National Heart Lung and Blood Institute Clinical guidelines on identification, evaluation and treatment of overweight and obesity in adults: the evidence report 1998.
40. Rexrode K.M., Carey V.J., Hennekens C.H., et al. Abdominal adiposity and coronary heart disease in women. The Journal of the American Medical Association 1998 Dec 2, 280(21):1843-1848.
41. Henrichot E., Juge-Aubry C.E., Pernin A., et al. Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 Dec, 25(12):2594-2599.
42. Wang Y., Lam K.S., Kraegen E.W., et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clinical Chemistry 2007 Jan, 53(1):34-41.
43. Hemdahl A.L., Gabrielsen A., Zhu C., et al. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 Jan, 26(1):136-142.
44. Choi K.M., Lee J.S., Kim E.J., et al. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. European Journal of Endocrinology/European Federation of Endocrine Societies 2008 Feb, 158(2):203-207.
45. de Lemos J.A., Morrow D.A., Blazing M.A., et al. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial. Journal of the American College of Cardiology 2007 Nov 27, 50(22):2117-2124.
46. Lee Y.H., Lee S.H., Jung E.S., et al. Visceral adiposity and the severity of coronary artery disease in middle-aged subjects with normal waist circumference and its relation with lipocalin-2 and MCP-1. Atherosclerosis 2010 Dec, 213(2):592-597.
47. Fain J.N., Madan A.K. Regulation of monocyte chemoattractant protein 1 (MCP-1) release by explants of human visceral adipose tissue. International Journal of Obesity 2005 Nov, 29(11):1299-1307.
48. Bruun J.M., Lihn A.S., Pedersen S.B., Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. The Journal of Clinical Endocrinology and Metabolism 2005 Apr, 90(4):2282-2289.
49. Fujikawa R., Ito C., Nakashima R., Orita Y., Ohashi N. Is there any association between subcutaneous adipose tissue area and plasma total and high molecular weight adiponectin levels?. Metabolism: Clinical and Experimental 2008 Apr, 57(4):506-510.
50. Ademi Z., Liew D., Chew D., et al. Drug treatment and cost of cardiovascular disease in Australia. Cardiovascular Therapeutics 2009 Fall, 27(3):164-172.
51. Ademi Z., Liew D., Hollingsworth B., Steg P.G., Bhatt D.L., Reid C.M. Predictors of annual pharmaceutical costs in Australia for community-based individuals with, or at risk of, cardiovascular disease: analysis of Australian data from the REACH registry. American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions 2010, 10(2):85-94.
52. Bhatt D.L., Steg P.G., Ohman E.M., et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. The Journal of the American Medical Association 2006 Jan 11, 295(2):180-189.
53. Treat-Jacobson D., Bronas U.G., Leon A.S. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication. Vascular Medicine (London, England) 2009 Aug, 14(3):203-213.
54. Saxton J.M., Zwierska I., Hopkinson K., et al. Effect of upper- and lower-limb exercise training on circulating soluble adhesion molecules, hs-CRP and stress proteins in patients with intermittent claudication. European Journal of Vascular and Endovascular Surgery 2008 May, 35(5):607-613.
55. Zwierska I., Walker R.D., Choksy S.A., Male J.S., Pockley A.G., Saxton J.M. Upper- vs lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: a randomized controlled trial. Journal of Vascular Surgery 2005 Dec, 42(6):1122-1130.
56. Bronas U.G., Treat-Jacobson D., Leon A.S. Comparison of the effect of upper body-ergometry aerobic training vs treadmill training on central cardiorespiratory improvement and walking distance in patients with claudication. Journal of Vascular Surgery 2011 Jun, 53(6):1557-1564.
57. Liusuwan R.A., Widman L.M., Abresch R.T., Johnson A.J., McDonald C.M. Behavioral intervention, exercise, and nutrition education to improve health and fitness (BENEfit) in adolescents with mobility impairment due to spinal cord dysfunction. The Journal of Spinal Cord Medicine 2007, 30(Suppl. 1):S119-S126.